Investigation and pending class action against Pfizer alleging Pfizer concocted uses for the drug Neurontin and promoted off-label uses for which the drug had no effect, and for which there is no scientific basis to prescribe the drug.
Neurontin was originally sold by Parke-Davis, which was a subsidiary of Warner Lambert, which in turn was acquired by Pfizer, Inc. in 2000-2001. Through its sales of Neurontin, these companies made profits which exceeded 3 billion dollars. The manufacturer of Neurontin fraudulently marketed this drug to doctors as a treatment for the following illnesses: Bipolar Disorder; Pain Syndromes; Peripheral Neuropathy; Diabetic Neuropathy; Reflex Sympathetic Dystrophy (RSD); Attention Deficit Disorder (ADD); Restless Leg Syndrome (RLS); Trigeminal Neuralgia; Essential Tremor Periodic Limb Movement; Migraines; Drug and Alcohol Withdrawal Seizures. If you were prescribed Neurontin as a treatment for any of the above illnesses, you may be entitled to reimbursement for the costs of this medicine and other damages.
Do not change medications without first consulting your doctor.